High amino acid concentrations in culture media trigger gluconeogenesis and mitochondrial activity, enabling accurate drug toxicity prediction.
A hybrid spheroid assay measures cancer stem cell proliferation using a fibroblast niche.
Segmented cell zones create a complex model that resolves the trade-off between accuracy and preparation time.
Differentiated endothelial cell populations resolve specificity loss by enabling high-throughput drug screening via microfluidic systems.
Seeding immature cardiomyocytes in a decellularized 3D cardiac extracellular matrix scaffold promotes structural maturation.
A process generates multicellular spheroids from tissue-derived single cells using an inert matrix to form three-dimensional structures.
A uremic toxin mixture induces endothelial cell dysfunction to create a vasculopathy model.
A cellular composite distributes chondrocytes within a 3D growth material and coats the surface with osteoblasts.
Ribosome inhibitor induces cancer stem cell dedifferentiation for organoid culture, overcoming chemoresistance via ATF3 signaling.
Segmenting primary tumor and gel layers resolves the contradiction between whole-body imaging limitations and quantitative metastatic potential evaluation.
Fusing cancer cells with normal lung organoids creates a human-relevant in vitro model that overcomes animal model limitations and ethical concerns.
A chemical cocktail induces senescence in human neurons, bypassing iPSC age-resetting limitations to enable accurate neurodegenerative disease modeling.
A computing device assigns stimulation protocols and scoring metrics to immature oocytes using biological sample data.
Culturing matrix cells with a ROCK inhibitor prevents dissociation and improves purity for alopecia treatments.
Culturing dissociated prostate cancer cells in a 3D extracellular matrix generates propagatable organoids that preserve primary tumor molecular diversity.
Extracellular matrix hydrogels combined with fibroblast supernatant enable reproducible bladder organoid generation for accurate preclinical cancer modeling.
Small molecule cocktails reprogram fibroblasts into therapeutic retinal cells, avoiding stem cell ethical concerns and tumor risks.
A micropatterned co-culture system maintains adult hepatocyte phenotype using intermediary non-parenchymal cells.
Yolk sac-mimic 3D organoids enable high-purity microglia production without cell sorting, resolving low yield and extended differentiation timelines.
Perfusion decellularized extracellular matrix scaffolds support organ-specific cellular differentiation and maturation in three-dimensional culture systems.
Selective culture medium isolates tumor cells from stromal interference, enabling accurate chemotherapy prediction within ten days.
A hydrogel substrate maintains cancer stem cells using glycosaminoglycan conjugates.
Synthetic PEG-heparin hydrogel supports stable three-dimensional neuronal networks, eliminating contamination risks from animal-derived components.
Pacing human pluripotent stem cell-derived cardiomyocytes at multiple fixed rates to measure compound responses across varying heart rhythms.
Genotoxic drug-treated tumor cells act as immunogenic vaccines to overcome low immune checkpoint inhibitor response rates.
Defined serum-free culture media maintain stemness during in vitro expansion, resolving donor shortages for corneal transplantation.
Targeted modulation of endothelial cell venuleness reduces adverse effects on healthy tissues during anti-inflammatory therapy.
Segmented Transwell inserts enable chronic monitoring of myeloid infiltration into cardiac tissue, resolving complexity trade-offs in disease modeling.
Artificial tumor environment enhances primary cell viability and proliferation in ex vivo drug testing systems.
Density centrifugation enriches cardiomyocyte precursors from human embryonic stem cell cultures.
Isolated TW-1 rat liver cancer stem cell line enables precise in vitro and in vivo drug screening models.
A porous natural polymer support and cartilage cell culture creates a mature tissue model for drug testing.
Conductive silicon nanowires create electrical networks in scaffold-free cardiac spheroids, resolving unsynchronized contractions by enhancing calcium handling.
Deep UV photochemical activation enables high-resolution micropatterning on soft substrates for cell culture applications.
A high-throughput iPSC-based screening platform identifies therapeutic agents that enhance myogenic fusion in patient-derived myoblasts.
ZYXY-T1 cell strain preserves ETP-ALL antigen profiles to resolve limited research models and improve drug screening reliability.
Hydrophobic liquid pearls encapsulate cells in methylcellulose hydrogels for 3D organoid generation.
Timed growth factor exposure generates myelinating oligodendrocytes in human cortical spheroids.
Tie2-expressing monocytes resolve therapy complexity by serving as living vectors that deliver therapeutic genes to specific angiogenic sites.